LRMR
Larimar Therapeutics Inc
3.30$
-14.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.7% | 94.0% | 93.0% | 97.5% | 97.4% | 97.5% | 97.2% | 97.0% | 97.8% | 97.4% | 98.3% | 97.2% | |
| 37.2% | 27.9% | 44.4% | 13.6% | 16.0% | 16.6% | 12.4% | 13.7% | 48.1% | 58.6% | 85.3% | 56.1% | |
| 92.0% | 90.5% | 91.6% | 95.3% | 93.0% | 91.6% | 92.6% | 92.4% | 93.6% | 93.8% | 96.1% | 94.5% | |
| – | 0.3% | 0.4% | 0.3% | 0.4% | 0.5% | 0.6% | 0.7% | 0.5% | 0.5% | 0.4% | 0.2% | |
| – | – | – | – | -0.4% | – | – | – | – | – | – | – | |
| 10.8% | 14.8% | 7.0% | 10.9% | 9.4% | 14.2% | 15.2% | 20.1% | 25.8% | 46.5% | 24.2% | 22.9% | |
| 6.3% | 9.9% | 5.2% | 8.9% | 7.4% | 12.2% | 13.0% | 17.8% | 24.1% | 44.4% | 22.9% | 20.7% | |
| 0.7% | 0.9% | 0.3% | 0.4% | 0.5% | 0.5% | 0.6% | 0.8% | 0.6% | 0.8% | 0.5% | 0.7% | |
| 0.7% | 1.3% | 0.8% | 1.2% | 0.8% | 1.2% | 1.3% | 2.8% | 5.9% | 3.6% | 4.1% | 4.6% | |
| 89.2% | 85.2% | 93.0% | 89.1% | 90.6% | 85.8% | 84.8% | 79.9% | 74.2% | 53.5% | 75.8% | 77.1% | |
| -168.9% | -196.5% | -81.9% | -94.8% | -109.7% | -134.4% | -175.4% | -216.4% | -198.7% | -298.2% | -222.7% | -300.8% | |
| 42.2% | 45.8% | 21.6% | 26.9% | 29.1% | 31.9% | 37.6% | 42.7% | 41.8% | 58.4% | 40.9% | 62.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.